Cargando…

Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan

The present case is the first report in Japan in which a breast cancer was discovered as a result of prospective magnetic resonance imaging (MRI) screening study for BRCA1/2 mutation carriers who were free of breast or ovarian cancer. This case is significant and it verifies the importance of MRI sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tozaki, Mitsuhiro, Nakamura, Seigo, Kitagawa, Dai, Iwase, Takuji, Horii, Rie, Akiyama, Futoshi, Arai, Masami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society for Magnetic Resonance in Medicine 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600036/ https://www.ncbi.nlm.nih.gov/pubmed/28090007 http://dx.doi.org/10.2463/mrms.cr.2016-0090

Ejemplares similares

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ
por: Osako, Tomo, et al.
Publicado: (2014)

Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer
por: Tada, Keiichiro, et al.
Publicado: (2010)

Proposal of a novel method for observing the breast by high-resolution ultrasound imaging: understanding the normal breast structure and its application in an observational method for detecting deviations
por: Izumori, Ayumi, et al.
Publicado: (2011)

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers
por: Shimada, Satoko, et al.
Publicado: (2019)

BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ
por: Liu, Yan, et al.
Publicado: (2019)

The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan
por: Murakami, Wakana, et al.
Publicado: (2019)

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
por: Honma, Naoko, et al.
Publicado: (2015)

Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay
por: Osako, T, et al.
Publicado: (2012)

Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy
por: Sekine, Masayuki, et al.
Publicado: (2022)

Skin invasion and prognosis in node negative breast cancer: a retrospective study
por: Tada, Keiichiro, et al.
Publicado: (2008)

Clear Cell Sarcoma of the Neck Which Metastasized to the Mammary Gland
por: Fukada, Ippei, et al.
Publicado: (2013)

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype
por: Fukuda, Takayo, et al.
Publicado: (2016)

The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel
por: Fukada, Ippei, et al.
Publicado: (2017)

Mutation status of RAD51C,PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations
por: Sato, Katsutoshi, et al.
Publicado: (2017)

Current Status and Future Prospects of Proton MR Spectroscopy of the Breast with a 1.5T MR Unit
por: Tozaki, Mitsuhiro, et al.
Publicado: (2010)

Clinicopathological features of breast cancer patients with internal mammary and/or supraclavicular lymph node recurrence without distant metastasis
por: Inari, Hitoshi, et al.
Publicado: (2020)

Survival in Cytologically Proven Node-Positive Breast Cancer Patients with Nodal Pathological Complete Response after Neoadjuvant Chemotherapy
por: Inari, Hitoshi, et al.
Publicado: (2020)

Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities
por: Izumori, Ayumi, et al.
Publicado: (2019)

HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
por: van der Groep, Petra, et al.
Publicado: (2013)

Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast.
por: Munn, K. E., et al.
Publicado: (1996)

Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
por: Ding, Lina, et al.
Publicado: (2019)

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X
por: Yoshida, Reiko, et al.
Publicado: (2019)

Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence
por: Sato, Ayaka, et al.
Publicado: (2019)

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers
por: Faermann, Renata, et al.
Publicado: (2022)

Ductal Carcinoma in situ of the breast in sclerosing adenosis encapsulated by a hamartoma: A case report
por: Fukai, Shota, et al.
Publicado: (2018)

Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors
por: Abe, Shinya, et al.
Publicado: (2015)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients
por: Osako, Tomo, et al.
Publicado: (2017)

Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome
por: Kaneyasu, Tomoko, et al.
Publicado: (2020)

Ductal carcinoma in situ arises from microglandular adenosis and atypical microglandular adenosis in a young woman
por: Thu Huong, Nguyen, et al.
Publicado: (2023)

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative
por: Elsayegh, Nisreen, et al.
Publicado: (2015)

De-novo acute myeloid leukemia in a BRCA positive female with locally treated ductal carcinoma In Situ
por: Nabrinsky, Edward, et al.
Publicado: (2021)

Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
por: Yamauchi, Hideko, et al.
Publicado: (2023)

Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing
por: Elsayegh, Nisreen, et al.
Publicado: (2016)

Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients
por: Makita, Masujiro, et al.
Publicado: (2015)

The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study
por: Mitamura, Takashi, et al.
Publicado: (2021)

Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
por: Yamauchi, Hideko, et al.
Publicado: (2023)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sr6oqmd6kdsu5nq26hkr2bkgrj